|
Video: What is a Stock Split?
|
|
Conatus Pharmaceuticals is a biotechnology company focusing on the development and commercialization of medicines to treat chronic diseases. According to our CNAT stock split history records, CNAT has had 0 splits. | |
|
CNAT (CNAT) has 0 splits in our CNAT stock split history database.
Looking at the CNAT stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into CNAT shares, starting with a $10,000 purchase of CNAT, presented on a split-history-adjusted basis factoring in the complete CNAT stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/28/2014 |
|
End date: |
05/26/2020 |
|
Start price/share: |
$6.11 |
|
End price/share: |
$0.56 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-90.83% |
|
Average Annual Total Return: |
-32.49% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$916.61 |
|
Years: |
6.08 |
|
|
|
|
|